HomeCTX • TSE
add
Crescita Therapeutics Inc
Previous close
$0.43
Year range
$0.36 - $0.73
Market cap
8.39M CAD
Avg Volume
7.34K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 4.72M | -21.64% |
Operating expense | 3.17M | -4.23% |
Net income | -150.00K | -112.73% |
Net profit margin | -3.17 | -116.22% |
Earnings per share | — | — |
EBITDA | 161.75K | -80.81% |
Effective tax rate | 419.15% | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 9.39M | 12.97% |
Total assets | 24.60M | -13.64% |
Total liabilities | 5.78M | -21.82% |
Total equity | 18.82M | — |
Shares outstanding | 19.54M | — |
Price to book | 0.46 | — |
Return on assets | -1.13% | — |
Return on capital | -1.39% | — |
Cash Flow
Net change in cash
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -150.00K | -112.73% |
Cash from operations | -261.00K | 88.22% |
Cash from investing | -105.00K | -41.89% |
Cash from financing | -258.00K | -16.74% |
Net change in cash | -636.00K | 74.56% |
Free cash flow | -517.12K | 78.79% |
About
Founded
2016
Website
Employees
78